Literature DB >> 25530936

Standardizing MELD Exceptions: Current Challenges and Future Directions.

David S Goldberg1, Kim M Olthoff2.   

Abstract

Since MELD-based allocation was implemented in 2002, a system of exception points has been in place in order to award increased waitlist priority to those patients whose severity of illness or risk of complications are not captured by the MELD score. These exceptions, categorized as standardized and non-standardized, have been used with increasing frequency over time. Several challenges to the exception point system have emerged, including lack of standardization in the criteria used to approve such exceptions, geographic variability in the use and approval of such exceptions, and limited evidence base to support certain exceptions. Herein, we summarize the current implementation of exception points, the challenges facing the transplant community, and suggestions for improving and standardizing the current exception point system.

Entities:  

Keywords:  MELD exceptions; regional review boards; standardized exceptions

Year:  2014        PMID: 25530936      PMCID: PMC4267762          DOI: 10.1007/s40472-014-0027-4

Source DB:  PubMed          Journal:  Curr Transplant Rep


  23 in total

1.  Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy.

Authors:  Alessandro Cucchetti; Matteo Cescon; Eleonora Bigonzi; Fabio Piscaglia; Rita Golfieri; Giorgio Ercolani; Maria Cristina Morelli; Matteo Ravaioli; Antonio Daniele Pinna
Journal:  Liver Transpl       Date:  2011-11       Impact factor: 5.799

2.  Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.

Authors:  David Goldberg; Benjamin French; Peter Abt; Sandy Feng; Andrew M Cameron
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

3.  Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system.

Authors:  K Washburn; E Edwards; A Harper; R Freeman
Journal:  Am J Transplant       Date:  2010-05-10       Impact factor: 8.086

4.  Liver transplantation in the United States, 1999-2008.

Authors:  P J Thuluvath; M K Guidinger; J J Fung; L B Johnson; S C Rayhill; S J Pelletier
Journal:  Am J Transplant       Date:  2010-04       Impact factor: 8.086

5.  Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.

Authors:  Thomas Decaens; Françoise Roudot-Thoraval; Solange Hadni-Bresson; Carole Meyer; Jean Gugenheim; Francois Durand; Pierre-Henri Bernard; Olivier Boillot; Laurent Sulpice; Yvon Calmus; Jean Hardwigsen; Christian Ducerf; Georges-Philippe Pageaux; Sebastien Dharancy; Olivier Chazouilleres; Daniel Cherqui; Christophe Duvoux
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

6.  Exception point applications for 15 points: an unintended consequence of the share 15 policy.

Authors:  Therese Bittermann; George Makar; David Goldberg
Journal:  Liver Transpl       Date:  2012-10-10       Impact factor: 5.799

7.  An early regional experience with expansion of Milan Criteria for liver transplant recipients.

Authors:  J J Guiteau; R T Cotton; W K Washburn; A Harper; C A O'Mahony; A Sebastian; S Cheng; G Klintmalm; M Ghobrial; G Halff; L Mieles; J Goss
Journal:  Am J Transplant       Date:  2010-09       Impact factor: 8.086

Review 8.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

9.  Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.

Authors:  Neil Mehta; Jennifer L Dodge; Aparna Goel; John Paul Roberts; Ryutaro Hirose; Francis Y Yao
Journal:  Liver Transpl       Date:  2013-12       Impact factor: 5.799

10.  Hyponatremia and mortality among patients on the liver-transplant waiting list.

Authors:  W Ray Kim; Scott W Biggins; Walter K Kremers; Russell H Wiesner; Patrick S Kamath; Joanne T Benson; Erick Edwards; Terry M Therneau
Journal:  N Engl J Med       Date:  2008-09-04       Impact factor: 91.245

View more
  15 in total

1.  Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.

Authors:  Nadim Mahmud; Binu John; Tamar H Taddei; David S Goldberg
Journal:  Clin Transplant       Date:  2019-06-25       Impact factor: 2.863

2.  Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.

Authors:  Yan-Hua Lai; Wei-Dong Duan; Qiang Yu; Sheng Ye; Nian-Jun Xiao; Dong-Xin Zhang; Zhi-Qiang Huang; Zhan-Yu Yang; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

3.  An Advanced Practice Practitioner-Based Program to Reduce 30- and 90-Day Readmissions After Liver Transplantation.

Authors:  Nadim Mahmud; Samantha Halpern; Rebecca Farrell; Kate Ventura; Arwin Thomasson; Heidi Lewis; Kim M Olthoff; Matthew H Levine; Susanna Nazarian; Vandana Khungar
Journal:  Liver Transpl       Date:  2019-04-23       Impact factor: 5.799

4.  Definitive locoregional therapy (LRT) versus bridging LRT and liver transplantation with wait-and-not-treat approach for very early stage hepatocellular carcinoma.

Authors:  Peiman Habibollahi; Stephen Hunt; Therese Bitterman; Terence P Gade; Michael C Soulen; Gregory Nadolski
Journal:  Diagn Interv Radiol       Date:  2018-07       Impact factor: 2.630

5.  [Anesthesiological aspects of liver transplantation].

Authors:  S Dehne; F Lund; J Larmann; K Schmidt; T Brenner; M A Weigand; R von Haken
Journal:  Anaesthesist       Date:  2019-06       Impact factor: 1.041

6.  Waitlisted Candidates With Polycystic Liver Disease Are More Likely to be Transplanted Than Those With Chronic Liver Failure.

Authors:  Sahil D Doshi; Therese Bittermann; Thomas D Schiano; David Seth Goldberg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

7.  Predictors of outcomes following liver transplant in hepatopulmonary syndrome: An OPTN database analysis.

Authors:  Arun Jose; Shimul A Shah; Nadeem Anwar; Courtney R Jones; Francis X McCormack; Kenneth E Sherman; Jean M Elwing
Journal:  Respir Med       Date:  2021-11-11       Impact factor: 3.415

Review 8.  Advances in liver transplantation allocation systems.

Authors:  Michael L Schilsky; Maryam Moini
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 9.  Liver Transplantation for Cholestatic Liver Diseases in Adults.

Authors:  Vandana Khungar; David Seth Goldberg
Journal:  Clin Liver Dis       Date:  2015-10-23       Impact factor: 6.126

10.  Is the Pediatric End-stage Liver Disease Score Truly a Detriment to Pediatric Liver Allocation?

Authors:  Nadim Mahmud; Melissa M Gadsden; David S Goldberg
Journal:  JAMA Pediatr       Date:  2018-11-01       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.